Journal of Virology · 2020 · 12 citations · 37 references
Life SciencesMicrobiologyMolecular BiologyHost-pathogen InteractionsMolecular VirologyVirologyViral EntryViral GeneticsViral InfectionsViral StructureVirus EntryPlatelet-derived Growth Factor ReceptorsReceptor Binding SpecificitySubunit AssociationViral Entry ComplexesViral Entry InhibitorsViral Entry ReceptorsViral GlycoproteinsVirion Architecture
Human cytomegalovirus (HCMV) is known for its broad cell tropism, as reflected by the different organs and tissues affected by HCMV infection. Hence, inhibition of HCMV entry into distinct cell types could be considered a promising therapeutic option to limit cell-free HCMV infection. Soluble forms of cellular entry receptor PDGFRα rather than those of entry receptor neuropilin-2 inhibit infection of multiple cell types. sPDGFRα specifically interacts with gO of the trimeric gH/gL/gO envelope glycoprotein complex. HCMV strains may differ with respect to the amounts of trimer in virions and the highly polymorphic gO sequence. In this study, we show that the major gO genotypes of HCMV that are also found in vivo are similarly well inhibited by sPDGFRα. Novel gO genotypic forms potentially emerging through recombination, however, may evade sPDGFRα inhibition on epithelial cells. These findings provide useful additional information for the future development of anti-HCMV therapeutic compounds based on sPDGFRα.
37
Genetic content of wild-type human cytomegalovirus
Aidan Dolan, Charles Cunningham, Ralph D. Hector et al. · Journal of General Virology · 2004 · 571 citations · Full text